Standard and reduced doses of dabigatran, rivaroxaban and apixaban for stroke prevention in atrial fibrillation: a nationwide cohort study
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Internal Medicine"
DOI: 10.1111/joim.12683
Abstract: Comparative data of non‐vitamin K antagonist oral anticoagulants (NOAC) are lacking in patients with atrial fibrillation (AF). read more here.
Keywords: atrial fibrillation; standard reduced; rivaroxaban apixaban; doses dabigatran ... See more keywords